Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram website >

February 18, 2026

Patient with melanoma receives tumor-infiltrating lymphocyte therapy

The highly personalized treatment is currently approved for patients with advanced stages of melanoma whose tumors have grown despite immunotherapies and/or targeted therapies.

By Tom Wilemon
Before being sedated, Aaron Davis gives a thumbs up with his surgical team. (photo by Donn Jones)
February 12, 2026

Vanderbilt Health celebrates milestone for novel histotripsy procedure 

Appealing to patients for its noninvasive nature, it avoids many of the traditional drawbacks of surgeries that use incisions, including pain management. 

By Evan Dorian
John Bailey (courtesy/Sallie Bailey)
February 10, 2026

Wife of cholangiocarcinoma patient makes gift in honor of husband

After moving to Nashville in 2011, Sallie and John chose Vanderbilt Health for their care because they valued being part of a teaching hospital.

By Camille Amadeo Savell
February 5, 2026

DAISY Award spotlight: ‘You made the hardest season of my 21 years a little more bearable.’

Cody Stubblefield, RN, OCN, works in the cancer infusion center at Vanderbilt-Ingram Cancer Center. He is one of the latest Vanderbilt Health DAISY Award winners.

By Kylie Avery
February 5, 2026

DAISY Award spotlight: ‘Ashley greeted us with a smile that warms the heart.’

Ashley Colburn, BSN, RN, works at the Vanderbilt-Ingram Cancer Center Belle Meade. She is one of the latest Vanderbilt Health DAISY Award winners.

By Kylie Avery
January 12, 2026

Guide published for outpatient cancer treatment with bispecific antibodies

Vanderbilt-Ingram was among the first in the nation to establish outpatient protocols for another personalized immunotherapy, CAR-T.

By Tom Wilemon
December 8, 2025

Interim data reported for multiple myeloma off-the-shelf CAR-T therapy  

Vanderbilt-Ingram Cancer Center accrued the most patients nationwide for the clinical trial for P-BCMA-ALLO1 – a chimeric antigen receptor T cell therapy (CAR-T) derived from healthy donors’ white blood cells.
By Tom Wilemon
December 4, 2025

Vanderbilt-Ingram researchers present cancer advancements at ASH 2025 

Established in 1958, ASH is the world’s largest professional organization for clinicians and scientists who study blood diseases. 
By Tom Wilemon
December 2, 2025

Women who receive mammograms also undergo lung scans if notified of eligibility

Study showed that the improvement in lung cancer screenings exceeded the target enrollment set by the researchers.
By Tom Wilemon
November 4, 2025

Becker’s Hospital Review recognizes VUMC as a top oncology provider  

Vanderbilt-Ingram Cancer Center serves more than 49,000 distinct patients and manages over 250,000 outpatient visits annually.
By Tom Wilemon
October 30, 2025

Join Nicole Kidman in supporting breast cancer research and care

Kidman recorded a video alongside her friend Vandana Abramson, MD, co-leader of Vanderbilt-Ingram Cancer Center's Breast Cancer Research Program, sharing her story.
October 27, 2025

Macon County father’s voice restored following oral cancer surgery

After surgical removal of a rare tumor left a sizable hole inside Nick Schrock’s mouth, he could only speak in a muffled, lispy whisper. Tyler Ames, a dentist at VUMC, fashioned a prosthetic device to close the hole and allow Schrock to speak more clearly.
By Jill Clendening
October 23, 2025

New resources help people take action to prevent inherited diseases

To launch a connection search, someone with a specific gene variant signs up to meet others who share that variant, beginning a process of discovering new connections with unknown relatives and encouraging family members to get tested.
By Tom Wilemon